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Abstract 
Canine mammary tumours are highly heterogeneous in morphology and behaviour 
and successful clinical management requires robust prognostic factors. Histological 
grade, determined by the Nottingham method, has been considered one of these factors. 
Despite the adoption of this method, it is unknown if inter-observer agreement exists 
regarding the assessment of its parameters in canine mammary carcinomas (CMC). In 
this study, the agreement between two observers using the Nottingham method was 
evaluated in 89 CMC. Histological evidence of vascular invasion and/or lymph node 
metastases (both early signs of tumour aggressiveness) was recorded. For 48 animals, 
2–years follow-up data were available. Nuclear pleomorphism was quantitatively 
assessed using a stereological method, that allowed for an unbiased estimation of 
nuclear size and its variability, by determining the volume-weighted mean nuclear 
volume ( ̅V). Differences between the  ̅V estimations and the nuclear pleomorphism 
scores were evaluated. Additionally, the prognostic significance of clinicopathological 
features including nuclear score and  ̅V was evaluated.  
 
A poor agreement between the two observers was obtained (Kappa value 0.46).  
Tumours scored as 1 and 2 presented similar  ̅V and only tumours scored 3 presented 
significantly higher estimates. The  ̅V was not associated with vascular invasion and/or 
lymph node metastases, but was higher in tumours that progressed during follow-up. In 
multivariable analysis only tumour size was an independent factor regarding evidence 
of aggressiveness and an optimal cut-off of 2.9 cm was defined.   
 
Keywords: Canine; Mammary tumours; Histological grade; Nuclear volume; Prognosis; 
Stereology.  
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Introduction 
 Mammary gland tumours are the most frequent neoplasia in female dogs, 
particularly in countries where spaying is not performed routinely early in life 
(Sorenmo, 2003). Approximately half of the affected dogs have malignant disease based 
on the histopathological examination (Lana et al., 2007). Metastases to distant organs 
are the most common cause of morbidity and mortality associated with canine 
mammary tumours (Lana et al., 2007).  
 
Mammary neoplasia is a complex disease characterized by a heterogeneous 
clinical and biological behaviour. This probably contributes to the limited therapeutic 
options that are currently available (Goldschmidt et al., 2011; Klopfleisch et al., 2011, 
Sorenmo et al., 2011). Searching for new prognostic parameters is of utmost importance 
(Philibert et al., 2003; Chang et al., 2005; Santos et al., 2013). Histological grade is well 
established as an important prognostic factor in human breast cancer (Rakha et al., 
2010). In veterinary pathology, different grading systems have been used and claimed to 
have prognostic value, but such a variety of methods is itself a drawback (Goldschmidt 
et al., 2011; Matos et al., 2012).  
 
One of the most frequently used methods for histological grading of canine 
mammary tumours is the Nottingham method, originally developed for human breast 
cancer (Elston and Ellis, 1998). Karayannopoulou et al. (2005) provided some evidence 
that this method had advantages when compared to previous methods (that only use 
nuclear and cellular pleomorphism as parameters) for prognostic purposes in mammary 
tumours of dogs. The Nottingham grade method is based on the semi-quantitative 
assessment of three morphological features, namely, tubule formation, mitotic counts 
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and nuclear pleomorphism. The latter should mainly be evaluated by comparing the 
nuclear size and variation with normal mammary epithelial cells or lymphocytes (Elston 
and Ellis, 1998). Nuclear pleomorphism is considered a hallmark of malignant 
transformation and increases in the absence of cell differentiation.  
  
Irrespective of the method, grading is usually based on a subjective, experience-
dependent judgment by a pathologist, and on qualitative or semi-quantitative 
evaluations of morphologic and cytological features (Sørensen, 1992; Artacho-Pérula 
and Roldán-Villalobos, 1997). Not only the observer, but also the selection of the 
tumour areas to assess grade can significantly influence the scoring of the parameters. 
This is especially relevant for canine mammary tumours, which are intrinsically very 
heterogeneous (Klopfleisch et al., 2011).  
  
The subjective nature of morphological evaluation is associated with a high risk 
of inter- and intra-observer variations that can affect reproducibility and accuracy and 
limit comparative analysis between studies (Artacho-Pérula and Roldán-Villalobos, 
1997). A simple way to overcome such subjectivity is to use unbiased quantitative 
parameters for scoring neoplasms by applying appropriate stereological methods. This 
has been used in various tumour types, including human breast cancer (Sørensen, 1992; 
Ladekarl and Sørensen, 1993; Steiner et al., 1994; Artacho-Pérula and Roldán-
Villalobos, 1997; Ladekarl, 1998; Yörükoglu et al., 1998; Soda et al., 1999; Fujikawa et 
al., 2000). The design-based stereological estimates are precise, shape-independent, and 
allow for an objective evaluation of several cytological features, including nuclear 
pleomorphism (Ladekarl, 1998). However, to the best of our knowledge, stereological 
methods were never applied for studying canine mammary carcinomas (CMC).  
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The point-sampled intercepts (PSI) method is considered the easiest way to 
objectively quantify nuclear pleomorphism (Gundersen and Jensen, 1985; Ladekarl, 
1998). The PSI generates estimations of the volume-weighted mean nuclear volume,  ̅V 
(Sørensen, 1992). The  ̅V is not an intuitive parameter: it involves sampling the nuclei 
in proportion to their volumes, therefore reflecting nuclear size variation and 
pleomorphism (Sørensen, 1992). The  ̅V increases as the nucleus enlarges, and is 
further augmented when a substantial variation in nuclear size exists. This parameter is 
mostly used in histopathology, and the  ̅V estimate has been shown to provide relevant 
information in diagnosis and grading of breast tumours (Ladekarl and Sørensen, 1993; 
Artacho-Pérula and Roldán-Villalobos, 1997). 
 
The aims of this study were (1) to estimate the inter-observer variability in 
scoring nuclear pleomorphism-, using the criteria of the Nottingham grading system; (2) 
to assess nuclear pleomorphism of CMC using stereological tools, namely the PSI 
method; (3) to compare the stereological estimation with the histological score of 
nuclear pleomorphism; and (4) to verify the prognostic significance of the nuclear 
pleomorphism estimations by using univariable and multivariable analyses.  
 
Material and methods 
Clinical cases and histological analysis 
 In this study 89 spontaneous CMC (47 simple carcinomas and 42 complex 
carcinomas) from 56 female dogs that underwent surgical removal were analysed 
retrospectively. Owners gave informed consent for the surgery (with curative intents) 
and follow-up after declining postoperative adjuvant therapy. The protocol was 
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performed in compliance with the European Union Directives for the protection of 
animals used for scientific purposes (1999/575/CE and 2010/63/UE) and approved by 
the Ethics Committee of the Institute of Biomedical Sciences Abel Salazar, University 
of Porto. Tumours were accurately measured in the largest diameter with a calliper 
before surgery by the clinician (AdM or AS). Surgical techniques were decided on an 
individual basis and resulted in 47% radical, 26% regional and 17% local mastectomies. 
 
Histological and stereological evaluations were performed in all the slides 
resulting from one slab of the tumour, sectioned following the largest cross diameter of 
the tumour. The histological diagnosis was performed by two observers (MS and PDP) 
using the criteria of the World Health Organization classification (Misdorp et al., 1999). 
The presence of peritumoural vascular invasion and regional lymph node metastases 
was recorded. The lymph node status was evaluated in routine slides and after 
immunolabelling with pancytokeratin AE1/AE3 and cytokeratin 14, as previously 
described by Matos et al. (2006).  
 
The histological grading of nuclear pleomorphism was performed according to 
the Nottingham method criteria, considering luminal epithelial cells present in all the 
tumoural area. Briefly, nuclei were scored as: 1 if no visible increase in size and shape 
variability was detected compared to normal surrounding mammary epithelial cells; 2 
when moderate variation in size and shape existed (nuclei were generally larger than the 
normal ones); 3 when a marked increased variation in size and shape was present, with 
very large and bizarre forms observed in at least one quarter of the tumour area (Fig. 1). 
Two observers (MS and PDP) performed the nuclear grading independently in order to 
determine the inter-observer agreement. For cases with scoring discrepancy, a 
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consensus was subsequently reached by reviewing the slides using a multi-head 
microscope. 
 
Stereological analysis 
For the stereological analysis, all the tumour area of the slides was considered. 
As tumour size varied from 0.3 cm to 15 cm, an entire slab across the largest cross 
diameter resulted in one to nine slides. A systematic random sampling approach for the 
selection of the fields was used in each slide, meaning that the first field of sampling 
was randomly selected and thereafter fields were sampled systematically by adjusting 
the distance between individual fields of vision roughly proportional to the overall area 
of the tumoural tissue. The stereological analysis was performed with a workstation 
comprising a microscope (BX-50 Olympus) equipped with a 100x oil immersion 
objective (Olympus Uplan), a CCD video camera (Sony) connected to a PC monitor, 
and a motorized stage (Prior) for stepwise displacements in x-y directions; the 
workstation was controlled by the software CAST-Grid (v1.5, Olympus).  
 
The  ̅V was estimated by the PSI method (Gundersen and Jensen, 1985). This 
parameter quantifies the nuclear size and pleomorphism, estimated with a test-system 
made of parallel lines bearing a systematic pattern of points (Fig. 2). Only the nuclear 
profiles of epithelial cells hit by one of these points were sampled. On these profiles, the 
line segments overlying the nucleus were measured (from boundary to boundary) (Fig. 
2); this resulted in a length (l) that was used to estimate the  ̅V as follows (Gundersen 
and Jensen, 1985): 
3
0)3/()( lnucleusvv    
8 
 
For estimating the  ̅V, the average of total counted intercepts in each slide was 166 ( 
69 standard deviation or SD).  
 
Follow-up and survival study  
 The follow-up study was performed as described by Santos et al. (2011). Briefly, 
each female dog was evaluated prior to surgery, 3 weeks after the procedure and every 3 
months, thereafter for a 2-year period. Each evaluation included a complete physical 
examination, thoracic radiographs (3 views) and an abdominal ultrasound. Any clinical 
signs or lesions that could be related to tumour progression, either in the scheduled 
evaluations or in between them was thoroughly investigated (e.g. fine-needle aspirate, 
ultrasound-guided biopsy, and skeletal radiography). A complete necropsy was 
performed when the animals died spontaneously or were euthanised in search for 
evidence of subclinical local recurrence or metastatic disease. All suspected lesions 
were confirmed by histopathology.  
 
The survival analysis was performed following the most recent 
recommendations for prognostic studies in CMC (Matos et al., 2012), using only the 
cases presented as one malignant tumour per animal (n of animals = 40) and cases of 
multiple malignant tumours per animal with no evidence of disease progression 
(recurrence and/or metastases) during the follow-up period (n of animals = 8; n of 
tumours = 18). Overall survival (OS) was calculated from the date of surgery to the date 
of animal death/euthanasia due to tumour metastasis. Disease-free interval (DFI) was 
calculated from the date of surgery to the date of detection of tumour progression, i.e., 
confirmed local recurrence and/or metastases. In the survival study, cases were censored 
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if (1) animals died due to causes unrelated to tumour; (2) were lost to follow-up; and (3) 
were alive and free of distant metastases 24 months after surgery. 
 
Statistical analysis  
 Cohen’s Kappa statistic was used to assess the inter-observer agreement for the 
histological scoring of nuclear pleomorphism. An almost perfect and substantial 
agreement exists when the kappa value is comprised between 0.81 to 1 and 0.61 to 0.8, 
respectively. In contrast, when the kappa value is < 0.6, the agreement is considered 
moderate to poor (Vieira and Garrett, 2005). Additionally, an asymptotic marginal 
homogeneity test was used, to evaluate if statistical differences between the observers 
existed. ANOVA test and Tukey’s post-hoc multicomparison were used to assess for 
differences between the stereological values of  ̅V in each nuclear pleomorphism 
consensual score. Receiver operating characteristic (ROC) curves analyses were used to 
determine if tumour size and  ̅V values could discriminate tumours with or without 
evidence of vascular invasion and/or lymph node metastases.  
 
The association between clinicopathological parameters (tumour size, 
histological type, nuclear pleomorphism consensual score, and  ̅V) and the evidence of 
vascular invasion and/or lymph node metastases was assessed by logistic regression 
models. Pearson’s Chi-square or Fisher test (when the assumptions for the Pearson Chi-
square were not fulfilled) was used to assess which categorical variables should enter in 
the multivariable logistic model, while independent t test was used for continuous 
variables. In addition to the histological type, tumours were grouped for statistical 
purposes into two categories: (1) solid and anaplastic types and (2) tubulopapillary and 
complex types (one case of squamous cell carcinoma was excluded). This was 
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performed according to previous evidence that solid and anaplastic tumours show 
increased metastatic activity (Misdorp et al., 1999; Peña et al., 2013; Rasotto et al., 
2012).  As different categories of tumour size have been described in the literature, this 
parameter was analysed in three different ways: (1) as a continuous variable; (2) 
grouped according to the WHO criteria ( 3 cm; 3-5 cm;  5cm); or (3) categorized as 
suggested by Santos et al. (2011) ( 3 cm; ≥ 3 cm).  
 
A survival analysis of DFI and ODS was performed to determine if differences 
existed between the group with and without evidence of vascular invasion/lymph node 
metastases. The Kaplan-Meier plots were used to show differences between these 
groups. Finally, a log-rank test (Mantel-Cox) was applied to analyse the significance of 
the differences between groups. The same approach was used for the results of the ROC 
analysis if significant. The association of nuclear pleomorphism consensual score and 
 ̅V with survival data was also evaluated by univariable analyses. The counts of 
tumours with progression (recurrence and/or metastases and death) and tumours without 
events during the entire follow-up period were used for those univariable analyses. In all 
the tests, P < 0.05 was considered significant. Statistical analyses were performed with 
IBM SPSS Statistics 21. 
 
Results 
 The 89 tumours analysed included 42 complex carcinomas, 23 solid carcinomas, 
21 tubulopapillary carcinomas and 3 other carcinoma types (1 squamous cell and 2 
anaplastic carcinomas). In 26% of the tumours there was histological evidence of 
vascular invasion and/or lymph node metastases. Survival data were available for 58 
cases corresponding to 48 animals. From these, 10 animals progressed (recurred and/or 
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metastasized), 26 were disease-free at the end of the follow-up period, and the 
remaining were censored (5 died due to tumour unrelated causes, 5 were lost to follow-
up and 2 are still being followed). 
 
When scoring the nuclear pleomorphism, the two observers disagreed in 30/89 
cases (33.7%), with higher agreement in the score 3 comparing to scores 1 and 2 (Table 
1). The Kappa value was 0.46 (P < 0.001), thus indicating poor agreement. An 
asymptotic marginal homogeneity test was performed to evaluate whether there was a 
significant difference between the observers and none gave systematically lower or 
higher values than the other (P = 0.16). 
 
In each subtype of carcinomas (except for those named ‘other carcinomas’), 
score 2 was given to 50-60% of the cases. In solid and tubulopapillary carcinomas, 
score 3 represented 30-40% of the cases, while in complex carcinomas only 19% of 
cases were score 3. In the latter, 29% had score 1 in nuclear grade (Table 2). It is 
noteworthy that no association was detected between nuclear pleomorphism scores and 
histological types of CMC (P = 0.26).  
 
Regarding the histological type, no significant association with evidence of 
vascular invasion and/or lymph node metastases was detected. However, when the 
tumours where grouped into two histological type categories (solid plus anaplastic and 
tubulopapillary plus complex), it was noticed that the latter presented a low risk of 
vascular invasion and/or lymph node metastases comparing to the other category (P = 
0.01; Table 3).  In general, the stereological analysis was simple and the PSI method 
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lasted 10 to 15 min per slide. The mean  ̅V was 291  75 m
3
 and was 267  50 m3, 
265  50 m3 and 357  92 m3 in tumours with nuclear scores 1, 2 and 3, respectively.  
 
The ANOVA comparison between nuclear pleomorphism scores and  ̅V 
revealed significant differences between score 1 vs. 3 (P < 0.001) and 2 vs. 3 (P<0.001). 
Tumours scored as 1 and 2 did not differ significantly regarding their  ̅V. The 
histogram of  ̅V values showed a larger proportion of values around 300 m
3
, mainly 
including tumours with nuclear scores 1 and 2; a much smaller peak appeared to exist 
after 400 m3, corresponding to tumours that scored 3 in nuclear pleomorphism (Fig. 3).  
 
In univariable analysis, the  ̅V was not associated with histological evidence of 
vascular invasion and/or lymph node metastases. Therefore, in descriptive ROC 
analyses the discriminating power of the  ̅V estimations between tumours with and 
without histological evidence of vascular invasion and/or lymph node metastases was 
very low (AUC statistics 0.55; 95% confidence interval or CI, 0.41–0.70). According to 
the ROC findings, no optimal cut-off value of nuclear  ̅V, both with high sensitivity and 
specificity, could be defined for differentiating tumours with and without vascular 
invasion and/or lymph node metastases.  The  ̅V cut-off of 420 m
3
 provided 96% 
specificity, but only 22% sensitivity.  However, when the  ̅V values of the tumours that 
progressed (recurred and/or metastasized) were compared to those that did not progress 
during the follow-up, it was noticed that the mean  ̅V in the former was significantly 
higher (393  74 m3 versus 270  68 m3; P < 0.001).  
  
The nuclear pleomorphism score categories (score 1 plus score 2 versus score 3) 
were associated with evidence of vascular invasion and/or lymph node metastases (P = 
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0.02) and with tumour progression during the follow up (P < 0.001). In fact, only 
tumours scored as 2 or 3 showed histological evidence of vascular invasion and/or 
lymph node metastases and progression (in the latter, 9 out 10 were scored 3, with only 
one case being nuclear score 2).  
 
In multivariable analysis, histological type categories and nuclear pleomorphism 
score failed to retain their association with evidence of vascular invasion and/or lymph 
node metastases. Tumour size was the only factor with statistical significance as 
independent predictor of vascular invasion and/or lymph node metastases (Table 3).   
 
In the descriptive ROC analysis, the discriminative power of tumour size was 
high (AUC statistics = 0.80; range, 0.70-0.91) (Fig. 4). According to the ROC findings, 
the optimal cut-off tumour size value that would distinguish tumours with and without 
vascular invasion and/or lymph node metastases was 2.9 cm (sensitivity of 74% and 
specificity of 77%).  
 
Regarding the survival study, the mean DFI (14.2  2.7 months) and OS (15.2  
2.6 months) of the dogs bearing tumours with histological evidence of vascular invasion 
and/or lymph node metastization were significantly shorter than the DFI (22.4  0.9 
months) and OS (23.2  0.5 months) of the cases without such evidence (Fig. 5). The 
tumours were also grouped by the tumour size cut-off value previously determined by 
the ROC curve in order to perform a survival analysis (Fig.4). Tumours ≥ 2.9 cm in 
their maximum diameter were associated with poorer survival times (P = 0.04 for DFI 
and P = 0.02 for OS) (Fig.6). 
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Discussion  
In this study, a comprehensive evaluation of the nuclear pleomorphism of CMC 
and its prognostic value was performed. The tumours were divided according to the 
presence or absence of vascular invasion and/or lymph node metastases at the time of 
histological diagnosis, as previously described by Rasotto et al. (2012). This could be 
viewed as one of the earliest morphological signs of tumour aggressive behaviour and 
we propose that its recognition is essential for the development of effective post-
operative metastatic disease prevention strategies, like chemo- or radiotherapy. This 
assumption was supported by the survival analysis of this series, where tumours with 
histological evidence of vascular invasion and/or lymph node metastases had poorer 
survival after surgery, corroborating results from previous studies (Hellmén et al., 1993; 
Philibert et al., 2003; Chang et al., 2005).  
 
The inter-observer variability in grading nuclear pleomorphism using the 
Nottingham method criteria had not, to the best of our knowledge, been previously 
studied in CMC. In some of the most recent reports focusing on the use of the 
Nottingham method for mammary tumours of dogs, the number of observers and their 
concordance were not reported (Karayannopoulou et al., 2005; Clemente et al., 2010, 
Peña et al., 2013). In this study, there was a low agreement between the two observers 
regarding nuclear pleomorphism scoring. At a first glance, this fact could be a reason 
for concern since it anticipates a probable low reproducibility of histological grading in 
CMC. As already mentioned, CMC are highly heterogeneous tumours and an inherent 
subjectivity associated with the selection of the highly malignant areas is likely to occur 
(Ladekarl, 1998; Misdorp, 2002; Kamaki et al., 2006; Rakha et al., 2010). Moreover, 
according to our stereological findings, tumours with nuclear scores 1 and 2 had 
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objectively comparable  ̅V. Therefore, a lack of concordance between observers in 
these nuclear scores, as observed in this study, is more prone to occur. It is noteworthy 
that similar studies in human breast cancer concluded that the  ̅V estimations in score 1 
and score 2 were also similar (Artacho-Pérula and Roldán-Villalobos, 1997).   
 
The stereological assessment of nuclear pleomorphism by the PSI method uses a 
systematic random sampling, which is not only highly efficient but also obviates the 
subjectivity associated to the selection of the apparently more aggressive tumour areas 
(Ladekarl, 1998). To the best of our knowledge, nuclear pleomorphism in CMC has 
never been quantified using unbiased stereological techniques. According to our 
statistical analysis, the unbiased assessment of nuclear pleomorphism seems not to be 
related to the histological evidence of vascular invasion and/or lymph node metastases 
in CMC. However,  ̅V was significantly higher in tumours that recurred and/or 
metastasized during the 2-year follow-up period. This opens the possibility that this 
parameter may be regarded as a survival predictor like in humans, where it has been 
correlated with survival of patients affected by breast carcinoma (Artacho-Pérula and 
Roldán-Villalobos, 1997; Ladekarl, 1998).  
 
Canine and human mammary neoplasms are morphologically distinct. Yet, the 
Nottingham grading method was adapted to the dog, taking for granted that the 
evaluation of the parameters should be the same as used in human pathology (Matos et 
al., 2012; Peña et al., 2013), and the three scores of nuclear pleomorphism were 
considered without any validation studies. The present study showed that tumours 
scored 1 or 2 in nuclear pleomorphism presented similar mean nuclear volumes and that 
there was a marked low inter-observer concordance in nuclear score 1. Moreover, 
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nuclear score 3 was associated to a higher probability of vascular invasion and/or lymph 
node metastases, and poor survival. Therefore, only two nuclear grading scores appear 
to exist in CMCs: low grade and high grade, corresponding mostly to Nottingham 
nuclear scores 1 and 2 and to nuclear score 3, respectively.  
 
There is a general agreement that the tumour size of canine mammary tumours 
has a prognostic significance (Philibert et al., 2003; Chang et al., 2005; Sorenmo et al., 
2011). Our multivariable analysis results confirmed that tumour size represents an 
independent prognostic factor regarding the capacity of tumour vascular invasion and 
metastasis. Keeping in mind that different tumour size categories have been proposed 
and used (Misdorp, 2002; Santos et al., 2011; Peña et al., 2013), a ROC curve analysis 
was performed in order to define the tumour size threshold value with the highest 
sensitivity and specificity to predict aggressive tumour behaviour. Our results 
highlighted that tumours > 2.9 cm in their largest diameter were more associated to 
vascular system invasion and/or metastasis to the regional lymph nodes. The established 
cut-off of 2.9 cm supports that the tumour size categories (3 cm < and > 3 cm), defined 
by Sorenmo (2003) and used by Santos et al. (2011), are suitable for CMC and should 
be routinely applied for better reproducibility of future studies. Moreover, it indirectly 
supports the model proposed by Sorenmo et al. (2009) that correlates the development 
of a malignant phenotype with increased tumour size. According to our findings, 
tumour size does matters and clinicians should consider more radical surgical 
procedures and meticulous periodical follow-up evaluations of animals affected by 
malignant tumours > 3 cm with a special regard to the surgical removal of regional 
lymph nodes.  
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Unlike tumour size, nuclear pleomorphism was not an independent prognostic 
value when included in the multivariable model. This analysis obviates possible 
confounding factors when assessing prognostic factors and shows that that some 
parameters, although related to prognosis in univariable analysis, lose their value in 
multivariable models (Peña et al., 2013; Santos et al., 2013). We think that the role of 
nuclear pleomorphism as a prognostic factor deserves to be studied in larger series by 
multivariable survival analysis. 
 
A stereological tool was used to evaluate nuclear pleomorphism in CMCs. The 
estimates of  ̅V did not clearly discriminate tumours of the three different Nottingham 
nuclear scores. Some evidence that higher tumoural  ̅V could predict a poor animal 
outcome was provided by the present study. However, the analysed sample with follow-
up data, particularly the number of cases with tumour-related events, was relatively 
small, hampering further statistical analysis (e.g., a ROC curve analysis of the  ̅V 
values in tumours that progressed and tumours that did not progressed during the 
follow-up period). In addition, the role of this stereological evaluation of nuclear 
volume in other subtypes of canine mammary malignant tumours, like carcinosarcomas, 
remains to be determined.    
  
Conclusions 
This study provide evidence that the nuclear pleomorphism evaluation in CMC 
using the Nottingham method criteria is highly prone to inter-observer variability. 
Prospective studies of larger series and rigorous follow-up data are needed to validate 
the possibility that only two nuclear pleomorphism scores should be considered in 
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CMC. The  ̅V could provide an objective threshold allowing the differentiation between 
low and high nuclear grade, based on reliable survival information.  
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Tables  
Table 1: Results and concordance of the nuclear grading by the two observers. 
 
 
 Nuclear grade observer A 
Total 1 2 3 
Nuclear grade 
observer B 
1 8 4 0 12 
2 10 29 9 48 
3 1 6 22 29 
Total 19 39 31 89 
22 
 
Table 2: Nuclear grade scores, mean and standard deviation of volume-weighted mean 
nuclear volume ( ̅V) and frequency of vascular invasion and/or lymph node metastases 
in each carcinoma subtype (‘others’ include 1 squamous cell and 2 anaplastic 
carcinomas). 
 
 
 Histological type 
Nuclear score Solid (n=23) Tubulopapillary (n=21) Complex (n=42) Others (n=3) 
1 2 2 12 0 
2 12 12 22 2 
3 9 7 8 1 
 ̅V  (m
3
) 311(98) 295(82) 282(49) 248(116) 
Invasion/metastases 11 5 7 0 
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Table 3: Results of the univariable models and the final multivariable model using 
vascular invasion and/or lymph node metastases as the dependent variable in 89 canine 
mammary carcinomas.  
 
OR, odds ratio; CI, confidence interval; TP, tubulopapillary;  ̅V, volume-weighted 
mean nuclear volume, Ref, referent;  
 
 
Independent variables 
Univariable analysis Multivariable analysis 
OR 95% CI P   OR 95% CI P  
Histological type 
      
All categories       
TP Ref      
Solid 2.94 0.80 - 10.74 0.103    
Complex 0.64 0.17 - 2.32 0.498    
Others 0 0 - >100 0.991    
Two categories       
Solid and anaplastic Ref      
TP and complex  0.28 0.10 - 0.77 0.014 0.31 0.09 - 1.07 0.065 
Tumour size  
      
Continuum (cm) 1.50 1.21 - 1.87 <0.001 1.63 1.26 - 2.10 <0.001 
WHO categories       
 3cm Ref      
3 cm> and  5 cm 8.67 2.24 - 33.53 0.002    
> 5cm 12.43 3.47 - 44.43 <0.001    
Santos et al., 2011 categories       
 3cm Ref      
≥ 3cm 9.58 3.20 - 28.72 <0.001    
Nuclear pleomorphism  
      
Score 3 Ref      
Score 2 0.42 0.15 - 1.20 0.101    
Score 1 0 >0.001 - 0 0.991    
Two categories       
Score 1 and  2 Ref      
Score 3 3.42 1.26 - 9.29 0.017 2.57 0.76 - 8.63 0.126 
Nuclear  ̅V  (m3) 1.004 0.99 - 1.01 0.248    
24 
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Figure 1: Histological normal surrounding mammary tissue (A, C, E) and tumour cells 
(B, D, F) in three cases of canine mammary carcinomas.  Nuclear pleomorphism scoring 
followed the Nottingham method criteria: score 1 (image B) presents no increased size 
and shape variability comparing to normal epithelial cells (image A); score 2 (image D) 
has moderate variation and larger nuclei than normal ones (image C); whereas score 3 
(image F) shows marked increased variation in size and shape, with very large nuclei 
and prominent nucleoli comparing with normal adjacent parenchyma (image E). 
Haematoxylin-eosin, Bar, 20 m. 
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Figure 2: Estimation of the volume-weighted mean nuclear volume ( ̅V) with the point 
sampled intercepts method. A test system made of parallel lines bearing a systematic 
pattern of points is generated by the software. Nuclei in focus that are hit by one of the 
points are selected. In these nuclei, the distance between the intersections of the nuclear 
boundaries with the lines (marked with red crosses) was measured. Haematoxylin-eosin, 
Bar, 13m. 
 
 
Figure 3: Histogram of the volume-weighted mean nuclear volume ( ̅V) values of the 
89 canine mammary carcinomas. The higher peak of the values is around 300 m3. 
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Figure 4: Receiver operating characteristics (ROC) curve for tumour size values. The 
area under the curve (AUC) is 0.80 which indicates that tumour size has high 
discriminatory power between tumours with and without evidence of vascular invasion 
and/or lymph node metastases. An optimal cut-off of 2.9 cm with 74% sensitivity and 
77% specificity was defined.  
 
 
Figure 5– Kaplan-Meier disease free interval (DFI) and overall survival (OS) curves 
comparing cases with histological evidence of vascular invasion and/or lymph node 
metastases (dashed line) and cases without that evidence (continuous line) in 40 female 
dogs presenting a single mammary carcinoma. Vertical marks represent censored cases 
in each group. Histological evidence of vascular invasion and/or lymph node metastases 
was significantly associated to lower DFI and OS (P = 0.004 and P = 0.001, 
respectively). 
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Figure 6 – Kaplan-Meier disease-free interval (DFI) and overall survival (OS) plots. 
Tumours were grouped on the basis of optimal cut-off size value determined by ROC 
curve analysis: size  2.9 cm (continuous line) and size ≥ 2.9 cm (dashed line). Vertical 
marks represent censored cases in each group. Size ≥ 2.9 cm was associated to shorter 
DFI (P = 0.04) and OS (P = 0.02).  
